Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection.
D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004926:Escherichia coli / Q000187:drug effects; D007711:Klebsiella pneumoniae / Q000187:drug effects; D009268:Nalidixic Acid / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009391:Nephelometry and Turbidimetry; D011513:Proteus mirabilis / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001743:Urinary Bladder / Q000382:microbiology; D014552:Urinary Tract Infections / Q000188:drug therapy*
D009268:Nalidixic Acid; D012293:Rifampin